Aprotinin reduces vasoactive medication use during adult liver transplantation.

[1]  R. Schrier,et al.  Acute renal failure and sepsis. , 2004, The New England journal of medicine.

[2]  J. Findlay,et al.  Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double‐blind study , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  H. Putter,et al.  Reduced Need for Vasopressors in Patients Receiving Aprotinin during Orthotopic Liver Transplantation , 2000, Anesthesiology.

[4]  B. Hunt,et al.  Aprotinin: pharmacological reduction of perioperative bleeding , 2000, The Lancet.

[5]  L. Lindgren,et al.  Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.

[6]  S. Noble,et al.  Aprotinin , 2012, Drugs.

[7]  W. Wall,et al.  ADDITIONAL DOSE OF APROTININ MAY IMPROVE HEMODYNAMICS DURING POSTREPERFUSION PERIOD IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION (OLT) , 1998 .

[8]  E. Jaurrieta,et al.  The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study , 1997, Hepatology.

[9]  R. P. Kufner.  Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation. , 1997, Liver Transplantation and Surgery.

[10]  J. Vincent,et al.  Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. , 1997, Chest.

[11]  D. Royston,et al.  Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors. , 1996, International journal of cardiology.

[12]  K. Tan,et al.  Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. , 1995, British journal of anaesthesia.

[13]  P. Hayes,et al.  Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. , 1994, Clinical science.

[14]  A. Cumming.  Acute renal failure and sepsis: therapeutic approaches. , 1994, Nephrology, Dialysis and Transplantation.

[15]  S. Mallett,et al.  Impact of aprotinin on blood transfusion requirements in liver transplantation , 1993, Transfusion medicine.

[16]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[17]  R. Rossaint,et al.  Aprotinin in Orthotopic Liver Transplantation , 1993, Seminars in thrombosis and hemostasis.

[18]  S. Aggarwal,et al.  Hemodynamic instability during liver transplantation. , 1989, Transplantation proceedings.

[19]  M. Burritt,et al.  Hemodynamic and metabolic changes in hepatic transplantation. , 1989, Mayo Clinic proceedings.